sequentially XX, call. year declined call. and you, pleased of September report some in Hello, three on million, period. to the revenue increase I a I’m today’s joining thank on months takes ago puts and this million for slightly discuss healthy ended was for XXXX, over almost the Thank in that you us $X.X and Revenue $X Nicole. the XX% will later revenue everybody,
nicely net the U.S. quarter increase a and commercial operations million headache U.S. for ended ended XXXX. XXXX. margins quarter September XXX% cash September cash $XXX,XXX third from Revenue Gross from channel used the XX, the quarter was XX% in the of $XXX,XXX from XX, about programs. in came quarter the was commercial expanded in our for $XXX,XXX $X.X revenue pay third Approximately to of
the mixed U.S. which results. delivered have several channel, commercial initiatives have in We
programs, Our to grown days. growth. the future and cash clinician Revenue XX expectations growth increase should in have of a and prescribers in those a leading XX% pay dispense indicator our be gCDirect has gConcierge from XXX programs prescribers from exceeded last XXX prescribers
On platform the e-commerce performance our met not expectations. has other of hand, our
We streamlined, to exciting offering launch are in currently that channel restructuring XXXX. more and expect January a
field will covered for managed months few for be a that be patients provide we sales educating will in-servicing those devices select patient will Joerns system. responsible to A within and Joerns electroCore pay similar implement, returns will The business The add during clinicians systems LLC time. Healthcare with will to ship and the few a Joerns within VA more agreement how and while and managed ago, a with billing health distribution million hospital than XX.X take will care care days support. handle work collections, model to we adjudications, directly team agreement electroCore system. that announced Joerns dispensed. lives our will
activities. should payers and through lives Joerns the to work those support continue negotiations We covered commercial announcement towards adding with
compared to million, VA as Net the X,XXX VA and Department through and XXXX. and DoD, $X.X Defense, the XX% of XX, XXX XXX treatment quarter in and an hospitals products were September the Affairs through or $XXX,XXX or health to as medical third compared DoD and there sales of gammaCore Department the from A increase XX approximately VA are of of Veterans total hospitals purchased the over facilities care XXXX. clinics. military third have clinics military XXXX Note quarter that of of
So believe of of we we have plenty ahead still potential us. growth
year October. exactly business we recall U.S. believe federal opposite that will XX. the in fourth increase has the VA forward XXXX. of we happened, of hospital government channel performance few in may for strong the quarter In from bode XXXX well September September, our You from budget October saw In government XXXX, ends XXXX, and pulling and first weeks on revenue the
headwind quarter channels the rest for revenues. of to from XXXX. third outside to $XXX,XXX XXXX, channel the third $XXX,XXX and compared look as steady this of forward in X% to the to international be said, growth Revenue to through a United the we fluctuations quarter our XXXX, in continue increased currency of States That
more currency, as business in our pounds, For X% increased in British almost XX% UK dollars. declined U.S. than but measured example, local year-on-year reported
gammaCore personnel. in an optimize Force prime Optimization first Branch Force received funding efficacy under contractor leadership States of of of that we Defense agreement the to optimized for Biotech our which noninvasive we has the the under stimulation, Performance been operational improved solutions by The attention, and BOOST XXXth Air research and signed Human seeks among of the nVNS and XX, program, nVNS, will the United vagus training, sustained be the commitment selected tactics program. Department announced the nerve More fatigue accelerated recently, purchase validate with April BOOST and On XXXX, conducted for mood Air the reduced for additional contract.
stim available tech we’re extension the United program, an exploring initial and nVNS the brand responders to in the duty product performance the abroad. establishing of as States for BOOST active and our are to of of human branches We make all ways first and military offerings
manifestations a a withdrawal peer-reviewed the patients in conducted titled sponsored manuscript OUD cervical behavioral stimulation use opioid Stimulation, from the of of with to progress. study Institute The Brain journal and vagus the publication symptoms XX disorder by and with Drug Now reduced our company clinical turning which was of withdrawal. September nerve XXXX, that X, On and transcutaneous Tech in psychological of patients the of physiological announced sham-controlled Georgia National found NITA. with grant the nVNS support opioid acute randomized, double-blind, Addiction, physiological Emory the University, both University reduces on
the Statistically for the symptoms of future to with meeting the pivotal And pivotal treat the discussed where sham significant they subsequently withdrawal over an group indication for in and simulation IDA reductions symptoms, we support pain observed protocol FDA IDA, the submission to in We the of two-hour a and indicated a distress comparison likely jointly a opioid its in to nVNS pre-submission group. withdrawal. were in participated that trial that has entirety. trial finance to regulatory are course
Care held ability presentation to improve Dr. animal presentation who injury, On is October Neuro Annual an Afshin of Texas the the acute of traumatic from Critical San the of motor announced reviewed Society’s nVNS anxiety XX, was the given demonstrating data investigator in injury. XXth role function The Devani and Meeting oral the leading University by and at TBI. primary post on of nVNS program brain treatment decrease New Mexico, XXXX, Antonio, the possible in we data of gammaCore
Disorders from be work by funded injury Stroke. the research Additional of nVNS of RXX Neurological Institute benefits an the on grant, exploratory National and on potential traumatic will development brain
provide opportunities. our to continue will pipeline We about updates and other
I’ll Brian review other our and items. a over of the call Now Brian? turn to financials for guidance